RFU Startup Advances to Pivotal Next Stage

Resuscitation Therapeutics (RTx) – an early-stage company focused on developing new therapies for life-threatening acute cardiovascular events – is preparing an Investigational New Drug (IND) application for submission to the U.S. Food and Drug Administration proposing a novel treatment for sudden cardiac arrest (SCA). This case study is a phenomenal example of the success that life science startups are finding at the Rosalind Franklin University Innovation & Research Park. In Lake County, growing businesses are met with the leadership, resources and connections that they need to take operations to the next level.

Click here to learn more.